Burlington, Massachusetts, November 20, 2020 — Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based businesses, MilliporeSigma, EMD Serono, and EMD Performance Materials, have again been named to The Boston Globe’s annual “Top Places to Work 2020” list. The award gauges employee sentiments around company strategy and direction, culture, and benefits. Award rankings are based solely on survey responses provided by employees.
“Our Massachusetts-based employees have shown extraordinary focus and perseverance in the fight against Covid-19 as we collaborate with the global scientific community to fight the pandemic,” said Chris Ross, U.S. country speaker for the businesses of Merck KGaA, Darmstadt, Germany and interim CEO of MilliporeSigma. “Whether serving customers who are developing vaccines and diagnostics, working with the biopharma community to create, improve and prolong life, or enabling the development of next-generation digital devices and technologies, each of our businesses make a positive difference in our region and around the globe.”
This is the second time that all three Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany were recognized in the largest company category.
The Boston Globe annually recognizes more than 100 companies and organizations as the area’s leading employers. The three businesses of Merck KGaA, Darmstadt, Germany have a long history and strong community ties in Massachusetts, with some 3,000 employees working across several locations across the state.
Top Places to Work recognizes the best places to work in the state based on internal employee surveys. Employers who enter to be surveyed are placed into one of four groups: small, with 50 to 99 employees; midsize, with 100 to 249 workers; large, with 250 to 999; and largest, with 1,000 or more employees.
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of €16.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science and EMD Performance Materials.